Single Domain Antibodies Against Cll-1

text

Inventors

Roy Lobb, Paul Rennert

Assignees

  1. Aleta Biotherapeutics Inc.

Abstract

Antibodies that specifically bind to CLL-1 are described, as well as methods of making and using such antibodies. In one aspect, the present disclosure provides, among other things, antibodies, or antigen binding fragments thereof, that bind (e.g., selectively bind) CLL-1, compositions useful for binding CLL-1, and methods for treating disease comprising administration of such antibodies, or antigen binding fragments thereof.

CovalX Technology Used

Epitope Mapping

Contact our Scientific Team to Start the Conversation

Request A Call
Categories : Patents, Epitope Mapping
CovalX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.